Clinical Use of Lansoprazole and the Risk of Osteoporosis: A Nationwide Cohort Study

Background: Proton pump inhibitor (PPI) lansoprazole acts as a liver X receptor agonist, which plays a crucial role in the crosstalk of osteoblasts and osteoclasts in vitro and during bone turnover in vivo. However, epidemiological studies on the association between the use of lansoprazole and osteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Ming-Hsuan, Chen, Yong-Chen, Wu, Wen-Tung, Lin, Ming-Hsun, Yang, Yun-Ju, Hueng, Dueng-Yuan, Lin, Tsung-Kun, Chou, Yu-Ching, Sun, Chien-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696422/
https://www.ncbi.nlm.nih.gov/pubmed/36430077
http://dx.doi.org/10.3390/ijerph192215359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696422/
https://www.ncbi.nlm.nih.gov/pubmed/36430077
http://dx.doi.org/10.3390/ijerph192215359

Ejemplares similares